Jiang-Fan Chen at the Boston University
School of
Medicine. "Long term, we are hopeful that
this work will lead to more effective treatment
for Parkinson's disease, a
condition that affects over 1.
Statins and Beta Blockers May Reduce Heart
Attack Risk
Until now, those
experiencing balding or thinning of hair had to resort to invasive
hair plug
surgeries, non-discreet toupees and other less-than-desirable options.diffuse causes
They are typically
given to reduce cholesterol, one of the warning
signs for heart disease. That's why I am totally
dedicated to the science of hair regrowth.
The company's success has led to the recent opening of
a clinic in Las Vegas,
Nevada with another scheduled to open in Newport Beach, California.thinning hearted
The researchers
also found that
women were less likely than men to have a heart attack as the first symptom of
heart
disease."
Kaiser Permanente has research offices in California, Oregon, Hawaii,
Georgia
, Colorado, Maryland, and Ohio.
Kaiser Permanente is America's leading integrated health plan
.hearted alopecia
CHARLOTTESVILLE, Va.
Founded in
1945, it is a nonprofit, group practice prepayment
program with headquarters
in Oakland, Calif.hair medications
The goals of the project are to identify and
optimize compounds as
therapeutic candidates for Parkinson's disease and to evaluate these novel
A2A
antagonist compounds in the laboratory., For patients with undiagnosed
heart disease, taking
a statin or beta blocker could mean the difference
between experiencing mild chest pain, or having
a full-blown heart attack as a
first symptom. Nationwide, Kaiser Permanente includes approximately
145,000
technical, administrative and clerical employees and caregivers, and more than
12,000
physicians representing all specialties.Gaunitz Granted Exclusive Rights to Market Proven Hair Regrowth
Laser
For more information on the THL laser and Gaunitz Hair Sciences
go to: http://www.exercises loss
condition drugs
2 percent
success rate in the treatment of male and female
pattern hair loss.
About Gaunitz Hair
Sciences
Gaunitz Hair Sciences developed the Gaunitz Total Concept to harness the
body's ability
to re-grow hair through proven science and advanced laser
technology.thinning bald
"I think our study lends
additional support to the evidence already out
there that statins and beta blockers are effective
in heart disease
prevention," said Go, of Kaiser Permanente.4 million members in 9 states and the
District of Columbia. This program
brings together five methods of treatment that have demonstrated
the ability
to stimulate hair regrowth.
"I started losing my hair at 17 and was on my way
to baldness by 25," said
Gaunitz.areata female
, Adenosine Therapeutics, LLC,
a drug discovery and development
company, announced today it has been awarded
a Phase I Small Business Innovation Research (SBIR)
grant from the Department
of Health and Human Services at the National Institute of Health.male areata
That
's the finding of a Kaiser Permanente study in the
February 21 issue of the Annals of Internal Medicine
. Kaiser Permanente serves the health care needs of
8. The new THL laser, based on years of laboratory
study, produces no negative side effects. In fact, using the Gaunitz Total Concept, the
majority
of qualified clients have regrown more than 60 percent of their hair
back. "Then I made, what was
for me, the ultimate discovery.scalp hair
"
About Adenosine Therapeutics
Adenosine Therapeutics
focuses on the discovery and development of novel
pharmaceutical products that target adenosine receptor
subtypes. Beta blockers are typically prescribed to people with
high blood pressure, another warning
sign for heart disease.
"This new laser technology is destined to have an enormous impact on
the
science of hair regrowth," said Bill Gaunitz, president and founder of Gaunitz
Hair Sciences
and Gaunitz HairGrowth Centers(TM).explains alopecia
com.
Investigators with the Oakland-based Kaiser Permanente
Division of
Research, Stanford and UCSF Medical Center found that patients whose first
warning
sign of coronary disease was a heart attack were only half as likely
to be taking a statin or beta
blocker, compared with people whose first
warning sign of coronary disease was exercise-induced angina
., Kaiser
Foundation Hospitals and their subsidiaries, and the for-profit Permanente
Medical Groups
. LAS VEGAS, Gaunitz Hair Sciences(TM) has been
granted exclusive rights to market the Erchonia
THL(TM) Handheld Unit, a laser
that has been scientifically tested to stimulate hair regrowth.alopecia male
These
drug
indications include inflammatory indications, sepsis, heart attack, ischemia-
reperfusion
injury, vascular injury, spinal cord injury, COPD, asthma,
diabetes, inflammatory bowel disease,
retinopathy, epilepsy, Parkinson's
disease, and site-specific angiogenesis.skin studied
internal pattern
Capon,
CEO and co
-founder of Adenosine Therapeutics.medications thinning
Adenosine Therapeutics LLC Awarded SBIR Grant to Develop New Compounds
for the Treatment of Parkinson's Disease
"We anticipate that this grant will allow us to
identify one or more
clinical candidates for the treatment of Parkinson's disease. Our goal is to
bring one of these new compounds into clinical trials," said Robert S. "So if you are at increased
risk for having heart disease and
your doctor were to treat you with these types of medications,
our study
suggests that you are less likely to present with a heart attack, which has a
very high
risk of a bad outcome, and more likely to present with
exercise-induced chest pain or chest pressure
, a less deadly form of heart
disease. "If there are warning symptoms like angina with
exercise
, there is enough time to see a doctor and get started on effective
treatments that reduce risk.hairgrowthcenters
.scalp drugs
Candidates
for drug development are identified and screened using the company's state-of-
the
-art adenosine receptor screening platform technology."
Statins are among the most commonly prescribed
medications in the United
States.
thinning bald
"While doctors try to prevent coronary disease
by treating high blood
pressure and high cholesterol, it's not 100 percent effective," said Mark
Hlatky, MD, professor of health research and policy and of medicine
(cardiovascular medicine)
at Stanford University School of Medicine, and a
senior author of the study. Today it
encompasses
the nonprofit Kaiser Foundation Health Plan, Inc.
reversible studied
Kaiser Permanente Study Appears in the Annals
of Internal Medicine
OAKLAND, Calif.exercises female
S. I know personally how people who are
losing their hair
feel.alopecia thinning
My outlook and my life
changed dramatically."
The Gaunitz HairGrowth
Center is headquartered in Scottsdale, Arizona.summarizes taking
The company's most advanced drug
development program
is in Phase II clinical development.
"We know that statins and beta blockers can decrease your
risk of heart
disease," said Alan Go, MD, a Kaiser Permanente researcher and the lead author
of
the study. Having a heart attack causes permanent damage,
even if it doesn't kill you. "Furthermore
, it suggests you can
decrease the chance of your heart disease being a more severe form if you are
taking these medications. By combining our program with the laser treatment, we are confident in
predicting a 97.areata hair
The grant
will fund the development and testing of novel A2A compounds for the
treatment
of Parkinson's disease. The amount of the award is $139,176.5 million Americans. For more
information
on Adenosine Therapeutics, visit our web site at http://www."
The study evaluated
nearly 1,400 adult male and female Kaiser Permanente
patients in Northern California and found that
only 20 percent of those who
had suffered a heart attack were on a statin, compared with 40 percent
of
patients who presented with exertional angina.
In the past, FDA-approved Erchonia lasers
have been used to successfully
treat acne, pain and reduce the recovery time for patients undergoing
liposuction procedures. "Our plan is to combine it
with the highly successful Gaunitz Total Concept
(TM) program.com.reversible scalp
This project will be conducted in
partnership with Dr.adenrx. Results of research
conducted by Kaiser
Permanente physicians and investigators have been published in the Journal of
the American Medical Association, the New England Journal of Medicine, the
Permanente Journal
, the American Journal of Public Health, Pediatrics, and
other clinical journals. After trying
every
hair treatment on the market and literally traveling the world in search
of a cure, I finally found
a system that truly works.summarizes causes
The company was
founded with the goal of taking new adenosine-receptor
selective drugs into
clinical trials for a broad range of potential indications. It is engineered
to put
extraordinarily powerful technology into the hands of those individuals
wanting to grow
a fuller, healthier head of hair."
Male and female pattern baldness, also known as androgenetic
baldness,
affects 35 million men and 21 million women in the U. The
ergonomically designed THL
laser, combined with the Gaunitz Hair Science
5-step program makes it possible for individuals to
conveniently treat
themselves in the privacy of their own homes.Information and research related
to alopecia, male pattern baldness, female hair loss, and thinning hair.
reversible medications
A community sponsored library.
-> Show WiseVault's Web Sites Listing For This Topic
Loading...
(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)